Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,503Revenue (TTM) $M1,568Net Margin (%)9.1Altman Z-Score2.2
Enterprise Value $M814,647EPS (TTM) $3.0Operating Margin %14.1Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)13.3Higher ROA y-yN
Price/Book4,18510-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales1,3375-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %17.9ROA % (ttm)6.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)18.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M47.3ROIC % (ttm)9.0Gross Margin Increase y-yY

Gurus Latest Trades with CRL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CRLRobert Olstein 2016-09-30 Add0.33%$78.76 - $88.44
($83.83)
$ 74.15-12%Add 53.17%85,625
CRLJohn Rogers 2016-09-30 Reduce-0.04%$78.76 - $88.44
($83.83)
$ 74.15-12%Reduce -2.55%1,426,842
CRLJoel Greenblatt 2016-09-30 Sold Out -0.01%$78.76 - $88.44
($83.83)
$ 74.15-12%Sold Out0
CRLKen Fisher 2016-09-30 Reduce$78.76 - $88.44
($83.83)
$ 74.15-12%Reduce -1.45%508,660
CRLDavid Dreman 2016-06-30 Sold Out -0.49%$75.94 - $87.45
($82.27)
$ 74.15-10%Sold Out0
CRLRobert Olstein 2016-06-30 Add0.35%$75.94 - $87.45
($82.27)
$ 74.15-10%Add 130.18%55,901
CRLJohn Rogers 2016-06-30 Reduce-0.18%$75.94 - $87.45
($82.27)
$ 74.15-10%Reduce -12.17%1,464,130
CRLJoel Greenblatt 2016-06-30 Reduce-0.05%$75.94 - $87.45
($82.27)
$ 74.15-10%Reduce -83.12%11,856
CRLKen Fisher 2016-06-30 Reduce$75.94 - $87.45
($82.27)
$ 74.15-10%Reduce -2.59%516,128
CRLDavid Dreman 2016-03-31 Buy 0.49%$67.1 - $80.39
($74.1)
$ 74.150%New holding57,090
CRLRobert Olstein 2016-03-31 Buy 0.25%$67.1 - $80.39
($74.1)
$ 74.150%New holding24,286
CRLJohn Rogers 2016-03-31 Reduce-0.07%$67.1 - $80.39
($74.1)
$ 74.150%Reduce -4.36%1,666,955
CRLJoel Greenblatt 2016-03-31 Buy 0.06%$67.1 - $80.39
($74.1)
$ 74.150%New holding70,227
CRLKen Fisher 2016-03-31 Add$67.1 - $80.39
($74.1)
$ 74.150%Add 2.58%529,834
CRLDavid Dreman 2015-12-31 Sold Out -0.39%$61.75 - $80.54
($72.46)
$ 74.152%Sold Out0
CRLJohn Rogers 2015-12-31 Add0.07%$61.75 - $80.54
($72.46)
$ 74.152%Add 4.09%1,742,890
CRLJoel Greenblatt 2015-12-31 Sold Out -0.02%$61.75 - $80.54
($72.46)
$ 74.152%Sold Out0
CRLKen Fisher 2015-12-31 Add0.01%$61.75 - $80.54
($72.27)
$ 74.153%Add 6.96%516,495
CRLDavid Dreman 2015-09-30 Add0.02%$61.59 - $77.62
($71.85)
$ 74.153%Add 4.96%61,274
CRLJoel Greenblatt 2015-09-30 Buy 0.02%$61.59 - $77.62
($71.85)
$ 74.153%New holding29,055
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CRL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CRL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CHUBB STEPHEN DDirector 2016-12-02Sell4,564$71.574.76view
REESE C RICHARDDirector 2016-11-28Sell4,539$71.934.24view
Molho DavideCorporate Executive VP 2016-08-30Sell7,877$84.1-10.84view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell3,830$86.91-13.73view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell8,703$86.3-13.12view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell15,941$85.95-12.76view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell13,175$85.8-12.61view
FOSTER JAMES CChairman, President and CEO 2016-08-05Sell18,351$85.63-12.44view
WALLMAN RICHARD FDirector 2016-07-29Sell7,740$88-14.8view
MASSARO GEORGEDirector 2016-07-01Sell800$83.54-10.25view

Press Releases about CRL :

Quarterly/Annual Reports about CRL:

News about CRL:

Articles On GuruFocus.com
Bob Olstein's Olstein Strategic Opportunities Fund 2nd Quarter Commentary Sep 01 2016 
Olstein Strategic Opportunities Fund 1st Quarter Letter to Shareholders Jun 07 2016 
Olstein All Cap Value Fund First Quarter Commentary Jun 01 2016 
Weekly Highlight of CEO Sells Oct 13 2014 
John Rogers Comments on Charles River Laboratories Intl Inc Jul 22 2014 
John Rogers' Ariel Fund Second Quarter 2014 Commentary Jul 22 2014 
Robert Olstein’s Largest New Stock Picks Feb 12 2013 
Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE Jan 13 2013 
Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy" Jan 11 2012 
Stocks I Can Buy Much Cheaper Than Halvorsen Did Jan 11 2012 

More From Other Websites
Charles River Laboratories Demonstrates Expertise in CRISPR/Cas9 Genome Engineering Technology Dec 01 2016
Charles River Laboratories Demonstrates Expertise in CRISPR/Cas9 Genome Engineering Technology Dec 01 2016
Charles River upgraded by Barclays Nov 30 2016
Is Charles River Laboratories Intl. Inc (CRL) A Good Stock for Your Portfolio? Nov 26 2016
Charles River Laboratories Presents Robust Program at Neuroscience 2016 Nov 10 2016
Charles River Laboratories Presents Robust Program at Neuroscience 2016 Nov 10 2016
CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials Nov 08 2016
ETF’s with exposure to Charles River Laboratories International, Inc. : November 7, 2016 Nov 07 2016
Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q3, 2016 By the Numbers :... Nov 04 2016
Edited Transcript of CRL earnings conference call or presentation 2-Nov-16 12:30pm GMT Nov 02 2016
CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal... Nov 02 2016
Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today Nov 02 2016
Charles River beats 3Q profit forecasts Nov 02 2016
Charles River beats 3Q profit forecasts Nov 02 2016
Q3 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open Nov 02 2016
Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations Nov 02 2016
Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish... Oct 21 2016
ETF’s with exposure to Charles River Laboratories International, Inc. : October 19, 2016 Oct 19 2016
Charles River Announces Extension of Integrated Discovery Program with Genentech Oct 11 2016
Charles River Announces Extension of Integrated Discovery Program with Genentech Oct 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)